Pacific Biosciences Of California | PACB - Stock


Pacific Biosciences Of California reported $60.28M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Agilent USD 1.12B 28M Jun/2026
Bruker USD 1.12B 1.4M Jun/2026
Danaher USD 3.13B 126M Sep/2026
General Electric Aerospace USD 12.74B 303M Sep/2026
Illumina USD 667M 38M Sep/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
Pacific Biosciences Of California USD 60.28M 806K Sep/2026
Quidel USD 642.7M 23.8M Sep/2026
Revvity USD 388.85M 10.35M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
Standard Biotools USD 17.62M 514K Sep/2026
Thermo Fisher Scientific USD 5.64B 16M Sep/2026
Waters USD 1.32B 53M Sep/2026